Abstract
The diagnosis of infectious diseases is ineffective when the diagnostic test does not meet one or more of the necessary standards of affordability, accessibility, and accuracy. The World Health Organization further clarifies these standards with a set of criteria that has the acronym ASSURED (Affordable, Sensitive, Specific, User-friendly, Rapid and robust, Equipment-free and Deliverable to end-users). The advancement of the digital age has led to a revision of the ASSURED criteria to REASSURED: Real-time connectivity, Ease of specimen collection, Affordable, Sensitive, Specific, User-friendly, Rapid and robust, Equipment-free or simple, and Deliverable to end-users. Many diagnostic tests have been developed that aim to satisfy the REASSURED criteria; however, most of them only detect a single target. With the progression of syndromic infections, coinfections and the current antimicrobial resistance challenges, the need for multiplexed diagnostics is now more important than ever. This review summarizes current diagnostic technologies for multiplexed detection and forecasts which methods have promise for detecting multiple targets and meeting all REASSURED criteria.
Funder
National Institute of Biomedical Imaging and Bioengineering
Subject
Clinical Biochemistry,General Medicine
Reference125 articles.
1. Molecular Diagnostics,2017
2. Biomarkers: Potential uses and limitations
3. Biomarker detection technologies and future directions
4. Lipid biomarkers and long-term risk of cancer in the Women’s Health Study
5. The Value of Diagnostics Innovation, Adoption and Diffusion into Health Carehttps://www.lewin.com/content/dam/Lewin/Resources/Site_Sections/Publications/ValueofDiagnostics.pdf